IDEXX Laboratories, Inc. (IDXX)
After hours:
| Previous close | 465.82 |
| Open | 464.59 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 1000 |
| Day's range | 464.59 - 484.06 |
| 52-week range | 372.50 - 564.74 |
| Volume | |
| Avg. volume | 494,458 |
| Market cap | 40.081B |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | 49.24 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced the upcoming launch of the SNAP® Leish 4Dx® Test, a comprehensive screening test for vector-borne diseases, including canine leishmaniosis. The SNAP Leish 4Dx Test uses the trusted SNAP 4Dx Plus testing platform, which detects Lyme disease, heartworm disease, ehrlichiosis, and anaplasmosis. By replacing Lyme disease detection with detection of leishmaniosis, a more prevalent endemic disease in certai
- Business Wire
IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine, November 01, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results.
- Business Wire
IDEXX Laboratories to Release 2023 Third Quarter Financial Results
WESTBROOK, Maine, October 05, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 third quarter results for Wednesday, November 1, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
